SCN5A Variant L1255M
Summary of observed carriers, functional annotations, and structural context for SCN5A L1255M. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT3 penetrance
2%
0/11 effective observations
Estimated BrS1 penetrance
12%
1/11 effective observations
Total carriers
1
0 BrS1 · 0 LQT3 · 1 unaffected
Variant features alone are equivalent to phenotyping 1 individuals for Brugada syndrome and 0 individuals for LQT3.
In silico predictors
PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density BrS (%) | Penetrance Density LQT3 (%) |
---|---|---|---|---|---|
-1.65 | 0.918 | 1.41 | 0.774 | 12 | 0 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
Source | Year | Carriers | Unaffected | LQT3 | BrS1 | Other | Other Disease |
---|---|---|---|---|---|---|---|
Literature, cohort, and gnomAD | – | 1 | 1 | 0 | 0 | – | |
Variant features alone | – | 15 | 14 | 0 | 1 | – | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
Neighbour residue | Distance (Å) | Observed variants |
---|---|---|
1253 | 8 | E1253G, |
1211 | 14 | |
1267 | 12 | |
1252 | 6 | |
1262 | 11 | G1262S, |
1283 | 13 | L1283M, |
1280 | 13 | |
1247 | 12 | T1247I, |
1282 | 14 | S1282A, |
1259 | 7 | |
1257 | 8 | |
1256 | 5 | |
1250 | 10 | |
1275 | 12 | D1275N, |
1255 | 0 | L1255M, |
1251 | 6 | V1251M, |
1248 | 12 | |
1279 | 10 | V1279I, |
1258 | 5 | |
1254 | 5 | |
1207 | 14 | |
1276 | 11 | |
1278 | 14 | I1278N, |
1272 | 13 | |
1266 | 11 | |
1260 | 10 | A1260D |
1261 | 12 | |
1249 | 10 | V1249D, |
1263 | 12 |